Article
Prognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysis.
PloS one - 1 Jan 2014
Zhang Zhixuan, Wang Ting, Zhang Jun, Cai Xiaohong, Pan Changchuan, Long Yu, Chen Jing, Zhou Chengya, Yin Xude
Abstract excerpt
BACKGROUND: The prognostic value of epidermal growth factor receptor (EGFR) mutations in resected non-small cell lung cancer (NSCLC) remains controversial. We performed a systematic review with meta-analysis to assess its role. METHODS: Studies were identified via an electronic search on PubMed, Embase and Cochrane Library databases. Pooled hazard ratio (HR) for disease-free survival (DFS) and overall survival...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
